BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 24517573)

  • 1. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
    Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
    Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based inactivation of CYP2C11 by diclofenac.
    Masubuchi Y; Ose A; Horie T
    Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro.
    Wang Z; Gong Y; Zeng DL; Chen LG; Lin GT; Huang CK; Sun W; Chen MC; Hu GX; Chen RJ
    Pharmacology; 2016; 98(3-4):183-9. PubMed ID: 27287328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
    Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
    Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
    Murray M; Field SL
    Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.
    Gervasini G; Martínez C; Agúndez JA; García-Gamito FJ; Benítez J
    Pharmacogenetics; 2001 Feb; 11(1):29-37. PubMed ID: 11207028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat cytochrome P450 2C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol.
    Yamazaki H; Shimizu M; Nagashima T; Minoshima M; Murayama N
    Drug Metab Dispos; 2006 Nov; 34(11):1803-5. PubMed ID: 16896062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    Murray M
    Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase.
    Crespi CL; Miller VP
    Pharmacogenetics; 1997 Jun; 7(3):203-10. PubMed ID: 9241660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
    Butler AM; Murray M
    Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
    Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.
    Yasar U; Eliasson E; Forslund-Bergengren C; Tybring G; Gadd M; Sjöqvist F; Dahl ML
    Eur J Clin Pharmacol; 2001 Dec; 57(10):729-35. PubMed ID: 11829203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
    Tang C; Shou M; Rodrigues AD
    Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
    Voorman RL; Payne NA; Wienkers LC; Hauer MJ; Sanders PE
    Drug Metab Dispos; 2001 Jan; 29(1):41-7. PubMed ID: 11124228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2011; 63(6):1491-9. PubMed ID: 22358097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of human CYP2A6 and 2B6 and rat CYP2C11 and 2B1 in the 10-hydroxylation of (-)-verbenone by liver microsomes.
    Miyazawa M; Sugie A; Shimada T
    Drug Metab Dispos; 2003 Aug; 31(8):1049-53. PubMed ID: 12867494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.